文献速递肝病

活检证实的非酒精性脂肪性肝病患者严重感染风险——一项基于人群的队列研究

Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-05-26

该研究纳入1969至2017年瑞典所有经组织学确诊的非酒精性脂肪性肝病(NAFLD)成人12133例,并按年龄、性别、日历年及县匹配不超过5名人群对照(57516例)。中位随访14.1年,NAFLD患者严重感染住院风险高于对照(aHR 1.71,95%CI 1.63-1.79),且风险随组织学严重程度加重而升高,与同胞比较亦升高(aHR 1.54,95%CI 1.40-1.70)。

要点

  • NAFLD患者严重感染住院发生率32.3/1000人年,对照为17.0/1000人年,aHR 1.71(95%CI 1.63-1.79)。
  • 风险随组织学严重程度加重而升高,肝硬化患者aHR 2.32。
  • 与同胞比较,NAFLD患者严重感染风险亦升高(aHR 1.54,95%CI 1.40-1.70)。

核心结论

  • 活检证实的NAFLD患者发生需住院的严重感染风险显著高于一般人群及同胞,且风险随疾病严重程度加重而升高。

研究设计与样本

  • 基于人群的队列研究,纳入1969至2017年瑞典所有经组织学确诊的NAFLD成人12133例,并按年龄、性别、日历年及县匹配不超过5名人群对照57516例。

主要发现

  • 中位随访14.1年,NAFLD患者4517例(37.2%)因严重感染住院,对照为15075例(26.2%)。
  • NAFLD患者严重感染发生率为32.3/1000人年,对照为17.0/1000人年,aHR 1.71(95%CI 1.63-1.79)。
  • 最常见的感染为呼吸道感染(13.8/1000人年)和尿路感染(11.4/1000人年)。
  • NAFLD诊断后20年绝对风险差为17.3%,相当于每6例NAFLD患者中多1例严重感染。
  • 与同胞比较,NAFLD患者严重感染风险亦升高(aHR 1.54,95%CI 1.40-1.70)。

关键数值与推荐

  • 单纯性脂肪变aHR 1.64,非纤维化性脂肪性肝炎aHR 1.84,非肝硬化性纤维化aHR 1.77,肝硬化aHR 2.32。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It has been suggested that patients with nonalcoholic fatty liver disease (NAFLD) might be at increased risk of severe infections, but large-scale data from cohorts with biopsy-proven NAFLD are lacking. METHODS: Population-based cohort study including all Swedish adults with histologically confirmed NAFLD (n = 12,133) from 1969 to 2017. NAFLD was defined as simple steatosis (n = 8232), nonfibrotic steatohepatitis (n = 1378), noncirrhotic fibrosis (n = 1845), and cirrhosis (n = 678). Patients were matched to ≤5 population comparators (n = 57,516) by age, sex, calendar year, and county. Swedish national registers were used to ascertain incident severe infections requiring hospital admission. Multivariable adjusted Cox regression was used to estimate hazard ratios in NAFLD and histopathological subgroups. RESULTS: Over a median of 14.1 years, 4517 (37.2%) patients with NAFLD vs 15,075 (26.2%) comparators were hospitalized for severe infections. Patients with NAFLD had higher incidence of severe infections than comparators (32.3 vs. 17.0/1000 person-years; adjusted hazard ratio [aHR], 1.71; 95% confidence interval, 1.63-1.79). The most frequent infections were respiratory (13.8/1000 person-years) and urinary tract infections (11.4/1000 person-years). The absolute risk difference at 20 years after NAFLD diagnosis was 17.3%, equal to one extra severe infection in every 6 patients with NAFLD. Risk of infection increased with worsening histological severity of NAFLD (simple steatosis [aHR, 1.64], nonfibrotic steatohepatitis [aHR, 1.84], noncirrhotic fibrosis [aHR, 1.77], and cirrhosis [aHR, 2.32]. Also compared with their full siblings, patients with NAFLD were at increased risk of severe infections (aHR, 1.54; 95% confidence interval, 1.40-1.70). CONCLUSIONS: Patients with biopsy-proven NAFLD were at significantly higher risk of incident severe infection requiring hospitalization both compared with the general population and compared with siblings. Excess risk was evident across all stages of NAFLD and increased with worsening disease severity.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ebrahimi F, Simon TG, Hagström H, et al. Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study. Clin Gastroenterol Hepatol. 2023. PMID: 37245712. doi:10.1016/j.cgh.2023.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。